Bill and Melinda Gates Foundation

in page functions

The Bill & Melinda Gates Foundation has a permanent seat on the GAVI Alliance Board 

The Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation, which has a permanent seat on the GAVI Board, is also represented in the Executive Committee, in the Governance Committee and in the Programme & Policy Committee, guiding the activities of the Alliance.

The Bill & Melinda Gates Foundation is represented on the GAVI Alliance Board by:

Orin Levine (Representative)

Director of Vaccine Delivery, Global Development Program

Orin Levine 

Dr Levine leads the foundation’s efforts to accelerate the introduction of new vaccines and related technologies and to improve routine immunization systems. He is the Foundation’s focal point for engagement with the GAVI Alliance whose mission is saving children’s lives by increasing access to immunization in poor countries.

Before joining the foundation’s Global Development Program in 2012, Dr Levine was a Professor of International Health, and Executive Director of the International Vaccine Access Center (IVAC) at the Johns Hopkins University’s Bloomberg School of Public Health.

He has also served as a Steering Committee Member of the Decade of Vaccines Collaboration and Co-Chair of its Global Access Working Group, as well as President, Committee on Global Health, American Society of Tropical Medicine & Hygiene.

Dr Levine graduated with a Bachelor’s degree from Gettysburg College and received a PhD in epidemiology from The Johns Hopkins Bloomberg School of Public Health.

 

Steve Landry (Alternate)

Deputy Director, Vaccine Delivery

Steve Landry 

Serving as Deputy Director, Vaccine Delivery, for the Gates Foundation, Dr. Landry is responsible for the foundation’s new vaccine efforts, including its investments in GAVI and related activities. Before joining the foundation in 2004, Dr. Landry was the Senior Director of Program Financing for the GAVI Vaccine Fund. Prior to working with the Vaccine Fund, Dr. Landry worked with USAID, the last 3 years as a Senior Policy Advisor. He served as bilateral representative on the original GAVI working group and the Co-chair of the GAVI Financing Task Force.

Dr. Landry has a long history of supporting the introduction of new vaccines and technologies into the developing world. For over 10 years, at USAID he was responsible for accelerating the introduction of Haemophilus influenzae type b (Hib) and Pneumococcal conjugate vaccines into developing countries. Dr. Landry has also worked in vaccine development leading USAID’s Children’s Vaccine Program and the Malaria Vaccine Development Program.

Dr. Landry began his career in international development in the Peace Corps, where he served as a science teacher in a rural high school in Liberia. He holds a Ph.D. in medical entomology and vector borne disease modeling from the University of Wisconsin, Madison.

 

More on this topic

close icon

modal window here